跳至主要内容
临床试验/NCT00392223
NCT00392223终止3 期

A Phase III, Multicenter, Randomized, Double Blind-Double Dummy Study, To Evaluate Efficacy And Safety Of Treatment With Azithromycin, Microspheres, Oral Powder For Suspension, 2 G, In One Administration A Week, For 8 Weeks, Compared With Treatment With Minocycline Capsules, 100 Mg Die For 8 Weeks, In Outpatients With Moderate To Severe Inflammatory Acne.

Pfizer1 个研究点 分布在 1 个国家目标入组 118 人开始时间: 2007年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
终止
发起方
Pfizer
入组人数
118
试验地点
1
主要终点
Change From Baseline to End of Treatment in Global Acne Grading System (GAGS) Score

研究概览

简要总结

The primary objective is to evaluate the clinical efficacy of azithromycin microspheres treatment in outpatients with moderate to severe inflammatory acne compared with first line treatment minocycline after 8 weeks of therapy

详细描述

The study prematurely discontinued on the February 1, 2008 due to slow enrollment.It should be noted that safety concerns have not been seen in this study and have not factored into this decision.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • male and female, > 16 years of age, with diagnosis of acne papulo-pustular, moderate (19-30 GAGS score) to severe (31-33 GAGS score)

排除标准

  • pregnancy, gastrointestinal and endocrinological disease, specific systemic disease, hormonal contraceptives, isotretinoin, topic drugs for acne (except detergent allowed)

研究组 & 干预措施

Treatment Group A

Experimental

干预措施: Azithromycin microspheres (Drug)

Treatment Group A

Experimental

干预措施: minocycline-placebo capsules (Drug)

Treatment Group B

Experimental

干预措施: Azithromycin microspheres-placebo (Drug)

Treatment Group B

Experimental

干预措施: Minocycline capsules, (Drug)

结局指标

主要结局

Change From Baseline to End of Treatment in Global Acne Grading System (GAGS) Score

时间窗: Baseline, Week 8 End of Treatment (EOT)

GAGS used to assess 6 locations on face/chest/upper back; factor for each location based on surface area, distribution, density of pilosebaceous units. Locations graded separately 0 - 4 (hi). Global score factored based on summing of local scores. Change: (Global) score at observation minus (global) score at baseline.

Change From Baseline to End of Treatment (EOT) in Global Acne Grading System (GAGS) Score - Per Protocol Population

时间窗: Baseline, Week 8 EOT

GAGS used to assess 6 locations on face/chest/upper back; factor for each location based on surface area, distribution, density of pilosebaceous units. Locations graded separately 0 - 4 (hi). Global score factored based on summing of local scores. Change: (Global) score at observation minus (global) score at baseline.

次要结局

  • Change From Baseline in Global Acne Grading System (GAGS) Score(Baseline, Week 4, Week 8 End of Treatment (EOT), 8 weeks after EOT)
  • Improvement of Global Acne Grading System (GAGS) Score(Week 4, Week 8 End of Treatment (EOT), 8 weeks after EOT)
  • Change From Baseline in Acne Graded by Leeds Technique(Baseline, Week 4, Week 8 End of Treatment (EOT), 8 weeks after EOT)

研究者

发起方
Pfizer
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验